✦ LIBER ✦

Tolerability of oral and intravenous ibandronate (BONDRONAT®) treatment of metastatic bone disease in breast cancer

✍ Scribed by I. Schäfer; J. Seraphin; F. Schütze; A. Nusch; H. Meden; A.A. Kurth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ibandronate: a well-tolerated intravenou

✍ I.J. Diel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Pain reduction with oral and intravenous

✍ A.A. Kurth; J. Seraphin; F. Schütze; A. Nusch; I. Schäfer; H. Meden 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

448 Alleviation of bone pain with oral a

✍ D. Tripathy; J.J. Body; I. Diel; B. Bergstrom 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Intravenous and oral ibandronate provide

✍ J Body; D Tripathy; R Bell; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Oral versus intravenous ibandronic acid:

✍ Kyriaki Mystakidou; Evangelia Stathopoulou; Efi Parpa; Vassilios Kouloulias; Eva 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 324 KB

443 Safety and tolerability of oral iban

✍ I. Diel; M. Pecherstorfer; J.J. Body; D. Tripathy; B. Bergstrom 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB